1987
DOI: 10.1136/bmj.294.6588.1660 View full text |Buy / Rent full text
|
|

Abstract: implications regarding the metabolic defect responsible for the clinical features of Huntington's disease. It also suggests a role for manipulation of the striatonigral neurotransmitter pathway in treatment and presymptomatic testing for this condition.

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
2
0

Publication Types

Select...

Relationship

0
0

Authors

Journals